Skip to content

Intravoxel incoherent motion derived liver perfusion/diffusion readouts can be reliable biomarker for the detection of viral hepatitis B induced liver fibrosis

Intravoxel incoherent motion derived liver perfusion/diffusion readouts can be reliable biomarker for the detection of viral hepatitis B induced liver fibrosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123673
Enrollment
Unknown
Registered
2026-04-28
Start date
2019-03-07
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

viral hepatitis B induced liver fibrosis

Interventions

patients with chronic hepatitis B:None
healthy control group:None

Sponsors

Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 64 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of patients of viral hepatitis B : 1. The patient has been HBsAg positive for at least 6 months; 2. Agree to liver biopsy histological examination; 3. Individuals without severe claustrophobia and able to cooperate with MRI scanning for breathing and breath holding requirements. Inclusion criteria of healthy volunteers: no severe claustrophobia, no history of hepatitis and other chronic liver diseases, and no obvious abnormality in two and a half pairs of hepatitis B B and liver function tests after inclusion.

Exclusion criteria

Exclusion criteria: 1. Patients with co-infection of other hepatitis viruses, alcoholic and non-alcoholic liver diseases, and other liver diseases; 2. Patients who have not obtained biopsy specimens and thus cannot undergo histopathological examination; 3. Patients whose images contain a large amount of respiratory artifacts and cannot be post-processed.

Design outcomes

Primary

MeasureTime frame
true diffusion coefficient;pseudo diffusion coefficient;perfusion fraction;area under the curve;

Countries

China

Contacts

Public ContactRong Pengfei

Third Xiangya Hospital , Central South University

1342932091@qq.com+86 187 1114 2583

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026